{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:18:12Z","timestamp":1787242692925,"version":"build-2736575974"},"reference-count":15,"publisher":"Society of Nuclear Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,3,17]]},"published-print":{"date-parts":[[2026,7]]},"DOI":"10.2967\/jnumed.126.272204","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T18:35:18Z","timestamp":1776364518000},"page":"1097-1101","source":"Crossref","is-referenced-by-count":1,"title":["Utility of PSMA PET\/CT After an Initial Negative Scan: Results from a Prospective Multicenter PSMA PET Registry"],"prefix":"10.2967","volume":"67","author":[{"given":"Ur","family":"Metser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Bauman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Ali","family":"Mirshahvalad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Kohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"2026070106450723000_67.7.1097.1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41391-022-00544-3","article-title":"The impact of PSMA PET on the treatment and outcomes of men with biochemical recurrence of prostate cancer: a systematic review and meta-analysis","volume":"26","author":"Pozdnyakov","year":"2023","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"2026070106450723000_67.7.1097.2","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1148\/radiol.211824","article-title":"Effect of 18F-DCFPyL PET\/CT on the management of patients with recurrent prostate cancer: results of a prospective multicenter registry trial","volume":"303","author":"Metser","year":"2022","journal-title":"Radiology."},{"key":"2026070106450723000_67.7.1097.3","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.269653"},{"key":"2026070106450723000_67.7.1097.4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00644"},{"key":"2026070106450723000_67.7.1097.5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.4853"},{"key":"2026070106450723000_67.7.1097.6","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jamaoncol.2023.0161","article-title":"Addition of metastasis-directed therapy to intermittent hormone therapy for oligometastatic prostate cancer: the EXTEND phase 2 randomized clinical trial","volume":"9","author":"Tang","year":"2023","journal-title":"JAMA. Oncol."},{"key":"2026070106450723000_67.7.1097.7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00985"},{"key":"2026070106450723000_67.7.1097.8","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1186\/s12885-019-6117-z","article-title":"Radioablation +\/\u2212 hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): potential of imaging and biology (AIRC IG-22159)","volume":"19","author":"Marvaso","year":"2019","journal-title":"BMC Cancer."},{"key":"2026070106450723000_67.7.1097.9","doi-asserted-by":"crossref","first-page":"S2643","DOI":"10.1016\/S0167-8140(24)03363-2","article-title":"3381: primary endpoint analysis of TRAP, first prospective phase II trial of SBRT to oligoprogressive disease prostate cancer (NCT03644303)","volume":"194","author":"Patel","year":"2024","journal-title":"Radiother Oncol."},{"key":"2026070106450723000_67.7.1097.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2021.02.031"},{"key":"2026070106450723000_67.7.1097.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.04.029"},{"key":"2026070106450723000_67.7.1097.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.198119"},{"key":"2026070106450723000_67.7.1097.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.235028"},{"key":"2026070106450723000_67.7.1097.14","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1080\/0284186X.2020.1790655","article-title":"Is there a role for repeating PSMA PET\/CT after a negative scan in biochemical recurrent prostate cancer?","volume":"59","author":"Mjaess","year":"2020","journal-title":"Acta Oncol."},{"key":"2026070106450723000_67.7.1097.15","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.267591"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.126.272204","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:05:18Z","timestamp":1782914718000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.126.272204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":15,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,1]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.2967\/jnumed.126.272204"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.126.272204","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]}}}